Clinical Trial Update: Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia

View source ↗

Summary

Non-interventional, open-label observational study comparing adherence to Azithromycin SR versus Amoxiclav 1000 mg in adults with mild-to-moderate community-acq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Amoxiclav 1000 mg (amoxicillin/clavulanate)
• Azithromycin SR (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Community-Acquired Pneumonia | Status: TERMINATED | Results posted: 2011-12-21